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Abstract
Early detection of a premalignant or cancerous oral lesion promises to improve the survival and
the morbidity of patients suffering from these conditions. Cytological study of oral cells is a non-
aggressive technique that is well accepted by the patient, and is therefore an attractive option for
the early diagnosis of oral cancer, including epithelial atypia and squamous cell carcinoma. However
its usage has been limited so far due to poor sensitivity and specificity in diagnosing oral
malignancies. Lately it has re-emerged due to improved methods and it's application in oral
precancer and cancer as a diagnostic and predictive method as well as for monitoring patients.
Newer diagnostic techniques such as "brush biopsy" and molecular studies have been developed.
Recent advances in cytological techniques and novel aspects of applications of scraped or exfoliative
cytology for detecting these lesions and predicting their progression or recurrence are reviewed
here.
Introduction
Oral cancer is the most common cancer and constitutes a
major health problem in developing countries, represent-
ing the leading cause of death. Although representing 2–
4% of the malignancies in the West, this carcinoma
accounts for almost 40% of all cancers in the Indian sub-
continent [1]. A key factor in the lack of improvement in
prognosis over the years is the fact that a significant pro-
portion of oral squamous cell carcinoma (OSCC) are not
diagnosed or treated until they reach an advanced stage.
This diagnostic delay may be caused by either patients
(who may not report unusual oral features) or by health
care workers (who may not investigate observed lesions
thoroughly) and it is presumed that such delays are longer
for asymptomatic lesions. The prognosis for patients with
OSCC that is treated early is much better, with 5-year sur-
vival rates as high as 80%. In addition, the quality of life
improves after early treatment, because cure can be
achieved with less complex and less aggressive treatment
than is necessary for advanced lesions.
A significant proportion of oral squamous cell carcinomas
(OSCC) develop from premalignant lesions such as leu-
koplakia and oral submucous fibrosis (Fig. 1). Adjuncts
for detection of lesions and selection of biopsy sites
include vital tissue staining (with Toluidine blue Fig. 2)
and exfoliative cytology. Unfortunately, sensitivity of
cytological diagnosis in a meta-analysis of 1306 cases
from 14 studies showed an average of only 87.4% (rang-
ing from 73.8 to 100%)[2]. Histological examination of
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tissue remains the gold standard for diagnosis and identi-
fication of malignant oral lesions. Biopsy is an invasive
technique with surgical implications, technique limita-
tions for professionals and psychological implications for
most patients. It also presents limitations when the
lesions are large and in these cases it is important to select
the most appropriate site of biopsy. Furthermore, even
though the biopsy study is fundamental, it is a diagnostic
method with limited sensitivity where one of the most
important features is the subjective interpretation of the
examining pathologist. These issues underline the impor-
tance of discovering and developing new diagnostic meth-
ods, improving the existing ones and discovering new
therapeutics targets for oral neoplastic diseases [3-6]. In
recent decades, we have seen a dramatic switch from his-
topathological to molecular methods of disease diagnosis
and exfoliative cytology has gained importance as a rapid
and simple method for obtaining DNA samples. Changes
occur at the molecular level before they are seen under the
microscope and before clinical changes occur. Identifica-
tion of high-risk oral premalignant lesions and interven-
tion at premalignant stages could constitute one of the
keys to reducing the mortality, morbidity and cost of treat-
ment associated with OSCC. In addition, certain patients
are known to be at high risk for head and neck cancer, spe-
cifically those who use tobacco or alcohol and those over
45 years of age. Such patients can be screened by physical
examination, and early-stage disease, if detected, is cura-
ble. Just as visual inspection of the uterine cervix has been
shown to be an unreliable means of identifying precancer
and cancer, clinical inspection of the oral cavity has been
shown to be equally unreliable in identifying precursor
lesions and early cancers. [7,8]. In a recent study of 647
lesions interpreted by academicians to be innocuous on
clinical inspection, 29 (4.5%) were confirmed to be dys-
plasia or carcinoma [9].
Cytological techniques
Oral brush biopsy
Oral cells can be obtained by different physical systems of
scraping the surface of the mucosa, by rinsing the oral cav-
ity or even by taking a sample of saliva from the patients.
The reliability of the different instruments used in oral
exfoliative cytology has been reviewed in different studies
[10,11]. The ideal instrument used for making a good
cytological smear should be easy to use in any location,
cause minimum trauma and provide an adequate and rep-
resentative number of epithelial cells [11]. It has been
shown that a brush is an adequate instrument due to its
ease in sampling and to the quality of the oral cytologic
sample (Fig. 3). Brush biopsy is a simple, relatively inex-
pensive, high sensitive, risk-free method of screening for
cancer and serves as an aid to the clinical examination
(Fig. 6, 7, 8). The improved accuracy is attributed to the
ease in obtaining full transepithelial cellular samples and
the evaluation of smears with an image analysis system
that has been adapted specifically to detect oral epithelial
abnormalities by some workers [12]. Full-thickness sam-
pling (indicated by pinpoint bleeding during procedure
Fig. 4) is essential if histomorphological, evaluation of the
collected cells is to yield representative findings. For
example, many dysplastic lesions are first identified in the
basal epithelial layers, and the diagnostic histomorpho-
Clinical picture of a patient with dysplasia of lower lip show- ing positive toluidine blue staining Figure 2
Clinical picture of a patient with dysplasia of lower lip show-
ing positive toluidine blue staining.
Clinical picture of a patient with oral submucous fibrosis of  lower lip Figure 1
Clinical picture of a patient with oral submucous fibrosis of 
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logical findings may be lost as the cells mature and parak-
eratin and keratin are produced (Fig. 5). To the classical
applications of the oral cytologic studies, such as oral can-
didiasis, others have been added, such as studying the epi-
thelial infection due to Epstein-Barr virus in oral lesions of
hairy leukoplakia, widening its possibilities [13]. The
importance of brush biopsy has been recently emphasized
in a multicenter study where nearly 5% of clinically
benign-appearing mucosal lesions were sampled by this
technique and later confirmed by typical scalpel biopsy to
represent dysplastic epithelial changes or invasive cancer.
[18] Other authors have also demonstrated the ability of
the brush biopsy to uncover similar type lesions that were
not clinically suspicious for carcinoma or preinvasive dis-
ease [14]. There are controversies related to the real value
of this technique in the early detection of OSCC. The exist-
ence of false positives has been pointed out showing high
sensitivity (90%) and low specificity (3%) [15]. Neverthe-
less, these data have been discussed previously [16]. In a
recent study by Potter et al., four false negatives of a total
115 analysed cases were found. Although the number of
false positive cases is small it is important to emphasize
that the mean delay time in diagnosing a carcinoma in
these cases was of 117.25 days [17]. However, more inde-
pendent studies analysing its true validity and reliability
as well as its applicability and its comparison with other
techniques are necessary. Multiple studies with different
results have been carried out, analysing the application of
the cytology in the detection of dysplastic lesions. In a
study from Sudan, oral scrape smear cytological analysis
has been proposed as a useful early diagnostic method for
epithelial atypia and therefore also for malignant oral
lesions [18]. Despite the improvements in the methods
used for collecting oral cytological material this method-
ology still presents problems in diagnosing oral cancer.
Problems are mainly due to the existence of false negatives
obtained as a result of a non representative sample as well
as the subjectivity of the cytologic evaluation [19].
Liquid based cytology
Since liquid-based cytology was developed in the 1990s
various comparative studies have shown that it can offer
significant advantages over conventional exfoliative cytol-
ogy. Results obtained from uterine cervix examination, for
example, have shown that the liquid-based preparations
reduce the problems related to sampling error, poor trans-
fer and fixation of the cellular sample [20-24]. In cervical
uterine cancer screening, the liquid-based preparations
have also demonstrated a significant reduction in false-
negative rates as compared with those of conventional
smears [20-23,25]. In a recent study from Brazil [26] the
liquid-based preparations resulted in higher specimen res-
olution as well as presenting a better cytological morphol-
ogy for pemphigus vulgaris, squamous cell carcinomas,
HSV lesions and fungus infections. For HSV lesions, in
particular, the observation of the cytopathological fea-
tures indicative of viral infections (binucleation, multinu-
cleated cells) greatly improved with the liquid-based
technique [26].
Application of techniques
Response to radiation therapy
Radiotherapy is frequently used as a standard treatment
for locally advanced carcinoma of oral cavity. Although
the response of malignant tumours and surrounding nor-
mal tissue to various doses of ionizing radiation is gener-
ally predictable, variability in the host-tumour reaction in
Picture demonstrating spreading of brush biopsy sample on a  slide Figure 4
Picture demonstrating spreading of brush biopsy sample on a 
slide.
Technique of brush biopsy emphasizing pin-point bleeding of  the oral mucosa Figure 3
Technique of brush biopsy emphasizing pin-point bleeding of 
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a specific individual makes the response unpredictable.
The cytological evaluation of sequential oral smears dur-
ing radiation therapy presents a unique opportunity to
study the radiation response of oral malignant tumours.
Earlier reports have described various cytoplasmic and
nuclear changes in a variety of malignant cells evaluated
by cytology after radiation therapy and included cellular
enlargement, vacuolization, cytoplasmic granulation,
nuclear enlargement, pyknosis, karyorrhexis, karyolysis,
multinucleation, micronucleation, nuclear budding and
binucleation (Fig. 9, 10). Later on micronucleation was
accepted as a reliable indicator for monitoring the effec-
tiveness of chemopreventive agents against cancer and for
monitoring the toxicity of chemicals. In a study by the
author comparing the post-radiation changes in normal
and malignant oral cells it was found that various mor-
phological abnormalities demonstrated a consistent sig-
nificant increase with radiation dose [27].
Apoptotic cells
In the smears of patients treated for OSCC, the percentage
of apoptotic cells has been studied [28]. This detection
can also be quite useful for monitoring patients' reaction
to chemotherapy.
Cytomorphometry
Ogden et al. [29] suggested that quantitative techniques,
based on the evaluation of parameters such as nuclear
area (NA), cytoplasmic area (CA), and nucleus-to-cyto-
plasm area ratio (NA/CA), may increase the sensitivity of
exfoliative cytology for early diagnosis of oral cancers,
since these techniques are precise, objective and reproduc-
ible. Cowpe et al. [30] demonstrated that exfoliative cytol-
ogy is capable of detecting malignant changes, through
estimation of NA/CA using the planimeter method in
Papanicolaou-stained smears. This study, published in
1985, concluded that 50 cells were sufficient to provide
indication of malignant changes. Since then, a number of
studies have been carried out using the technique
described by these authors to evaluate the influence of
diverse systemic and external factors on NA, CA and NA/
CA. In these studies planimeters have been replaced by
semiautomatic image analysis techniques, which are
faster, more accurate and more reproducible [31,32].
Cowpe et al. [33] found that tissues undergoing malig-
nant transformation typically show a reduction in CA
before the reduction in NA. They also suggested that sam-
ples of healthy mucosa from the same patient provide the
best control. Ramaesh et al. [34] used cytomorphometric
techniques to assess nuclear diameter (ND) and cytoplas-
mic diameter (CD) in normal oral mucosa, in dysplastic
lesions and in squamous cell carcinomas. They found that
CD was highest in normal mucosa, lower in dysplastic
lesions, and lowest in SCCs. By contrast, ND was lowest in
normal mucosa, higher in dysplastic lesions, and highest
in SCCs. These studies suggested that reduced nuclear size
and increased cytoplasm size are useful early indicators of
malignant transformation, and thus exfoliative cytology is
of value for monitoring clinically suspect lesions and for
early detection of malignancy.
Nuclear DNA content and DNA-image cytometry
Static cytometry permits the quantification of DNA con-
tent in cells obtained by exfoliative cytology. However,
Photomicrograph of a oral brush biopsy specimen from a  patient of squamous cell carcinoma buccal mucosa showing a  binucleated cell with evidence of intracellular and extracellu- lar keratinization in a inflammatory background Figure 6
Photomicrograph of a oral brush biopsy specimen from a 
patient of squamous cell carcinoma buccal mucosa showing a 
binucleated cell with evidence of intracellular and extracellu-
lar keratinization in a inflammatory background. (H & E × 
400).
Photomicrograph of a brush biopsy specimen from oral sub- mucousfibrosis showing anucleated hyperkeratinized cells  and a superficial squamous cell Figure 5
Photomicrograph of a brush biopsy specimen from oral sub-
mucousfibrosis showing anucleated hyperkeratinized cells 
and a superficial squamous cell. (H & E × 400).Molecular Cancer 2006, 5:11 http://www.molecular-cancer.com/content/5/1/11
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routine Haematoxylin-Eosin staining is inadequate for
this purpose, and special techniques are required to
ensure that staining intensity is in proportion to DNA
content. The Feulgen reaction meets this criterion, since it
is a stoichiometric procedure: in other words, each fixed
molecule of Schiff's reagent corresponds to a constant and
equivalent portion of the DNA molecule. The advantage
of this procedure is that staining intensities (and thus
DNA contents) can be determined automatically by spec-
trophotometry or densitometry as well as digital image
analysis [35].
Using cytology and DNA-image cytometry, it is easy to
prove that oral lesions with the diagnosis of lichen planus
and other inflammatory diseases show no suspicious
cells. A recent review of literature places the rate of malig-
nant transformation of lichen planus to squamous cell
carcinoma at 0.2% [36]. On the contrary, the presence of
malignant cells was demonstrated in one of 21 cases with
leukoplakia (4.76%), in all cases with erythroplakia and
in all squamous cell carcinomas. A meta-analysis of 2236
cases of leukoplakia from five studies has revealed a range
of malignant transformation of leukoplakia between 2.2
and 17.5%. Furthermore, Sciubba [37], Silverman et al.
[38] and Mashberg et al. [39] emphasized the fact that
erythroplakia, occurring as either an isolated lesion or as
a component of leukoplakia (erythroleukoplakia) is a
marker of severe epithelial dysplasia or carcinoma in situ.
In fact, 90% of erythroplakia were histologically diag-
nosed as in situ or invasive carcinomas. In one study, it
was shown that sensitivity of cytological diagnosis com-
bined with DNA-image cytometry may reach 100%,
whereas specificity was 97.4%. The authors reported a
case of erythroplakia in which intraobserver variability
among four pathologists led to diagnoses ranging from
mild to severe dysplasia and because of the cytological
and DNA cytometric diagnosis (severe dysplasia with
DNA aneuploidy), this case was finally diagnosed on early
cytological and DNA-cytometric diagnosis prior to the
histological diagnosis [40]. Remmerbach et al have
reported that sensitivity of cytological diagnosis com-
bined with DNA-image cytometry was 98.2% and specifi-
city 100%, when compared with the gold standard' of
histology [41]. In a study, Maraki et al. analyzed 150
patients with histologically proven epithelial dysplasia of
which 36 developed squamous cell carcinoma. DNA-
cytometry showed DNA-diploidy in 105 patients. 20
patients had DNA-polyploidy and in 25 patients DNA-
aneuploidy was found at the time of the initial diagnosis.
Carcinoma developed in only three of the 105 diploid
lesions when compared with 21 of the 25 aneuploid
lesions. Remmerbach et al. [42] concluded in the clinical
setting that DNA-aneuploidy might detect histologically
obvious malignancy, 1–15 months prior to histology.
Sudbo et al. analyzed archival material and reported that
the nuclear DNA-content in cells of oral leukoplakia may
be used to predict the risk of oral epithelial dysplasia up
to 5 years before histological diagnosis [43]. Based on
these observations, they proposed brush biopsies with
cytological/DNA-cytometric examination for microscopic
evaluation of white or red patches of the oral cavity (leu-
koplakia or erythroplakia). The finding of tumor cells or
Photomicrograph of a oral brush biopsy specimen from a  patient of squamous cell carcinoma of buccal mucosa with  high nucleo-cytoplasmic ratio coarsely granular chromatin  and a multinucleated cell showing evidence of vascular inva- sion Figure 8
Photomicrograph of a oral brush biopsy specimen from a 
patient of squamous cell carcinoma of buccal mucosa with 
high nucleo-cytoplasmic ratio coarsely granular chromatin 
and a multinucleated cell showing evidence of vascular inva-
sion. (H&E × 1000).
Photomicrograph of a oral brush biopsy specimen from a  patient of squamous cell carcinoma of buccal mucosa with  high nucleo-cytoplasmic ratio marked atypia, and coarsely  granular chromatin in a necrotic background Figure 7
Photomicrograph of a oral brush biopsy specimen from a 
patient of squamous cell carcinoma of buccal mucosa with 
high nucleo-cytoplasmic ratio marked atypia, and coarsely 
granular chromatin in a necrotic background .(Modified pap × 
1000).Molecular Cancer 2006, 5:11 http://www.molecular-cancer.com/content/5/1/11
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DNA-aneuploidy should lead to a total excision of the
respective lesions and histological examination.
Molecular analyses
While the classic oral cytologic evaluation is labour inten-
sive and requires a high degree of expertise for identifying
and evaluating cells with suspicious morphology the anal-
ysis of molecular alterations is objective and tries to iden-
tify specific genetic anomalies [6]. The possibility of
extracting RNA from cells obtained by scraping has
recently been demonstrated emphasizing its usefulness in
the early diagnosis of oral premalignant and cancerous
lesions [44].
1. Gene alterations
Nowadays malignancy is considered as a process caused
by the accumulation of multiple genetic alterations,
which affect the cell cycle as well as normal cell differenti-
ation. These alterations are mainly acquired (somatic)
although some of them may be inherited and when they
activate protooncogenes, inactivate tumour suppressor
genes or affect enzymes, which repair DNA, they could
lead to a malignant transformation. Most of the oral cavity
carcinogens are chemical (tobacco), physical (radiation)
and infectious (Human papilloma virus, Candida) muta-
genic agents that may cause changes in gene and chromo-
some structure by point mutations, deletions, insertions
and rearrangements. However, some of these changes
may occur spontaneously. These genetic alterations,
which occur during carcinogenesis, can be used as targets
for detecting tumour cells in clinical samples [4,6,45].
Molecular analysis can identify a clonal population of
cancerous cells. Mutations in the tumour suppressor gene
p53 are the most frequent genetic alterations in human
cancer and show a variable frequency in oral cancer [46].
Several authors have studied and in some cases demon-
strated the potential clinical application of oral cytology
for detecting point mutations in p53 as a specific neoplas-
tic marker in OSCC [45,47-49]. However, other authors
consider that the high number of point mutations, which
can be found in p53, limit its potential clinical applica-
tion in cost-effective early detection of oral cancer [50].
2. Epigenetic alterations, Loss of hetrozygosity and 
Microsatellite instability
The applicability of other molecular markers such as epi-
genetic alterations (hypermethylation of promoter
regions) and genomic instability such as loss of hetrozy-
gosity (LOH) and microsatellite instability (MSI) has also
been studied. [50,51]. The main epigenetic modification
in tumours is methylation and it seems that the changes
in the methylation patterns can play an important role in
tumorigenesis. These epigenetic alterations are often asso-
ciated with the loss of genetic expression and their occur-
rence seems to be essential for the multiple necessary
genetic events. So malignant progression takes place
because these alterations can inactivate DNA repairing
genes. Rosas et al. studied the methylation patterns of
p16, MGMT and DAP-K genes in smears of patients suffer-
ing from head and neck cancer [50]. They detected abnor-
mal hypermethylation patterns in both kinds of samples
by a methylation specific Polymerase Chain Reaction
(PCR). They proposed that this technique allows a sensi-
tive and efficient detection of tumoral DNA and it is
potentially useful for detecting and monitoring recur-
rences in these patients. Loss of heterogeneity (LOH) and
other molecular changes indicative of oral carcinogenesis
can be readily identified in exfoliated cells [52-54]. Huang
Photomicrograph of malignant cells after radiation therapy  showing multiple nuclear budding Figure 10
Photomicrograph of malignant cells after radiation therapy 
showing multiple nuclear budding. (H&E × 1000).
Photomicrograph of malignant cells after radiation therapy  showing multinucleation and micronucleation Figure 9
Photomicrograph of malignant cells after radiation therapy 
showing multinucleation and micronucleation. (H&E × 1000).Molecular Cancer 2006, 5:11 http://www.molecular-cancer.com/content/5/1/11
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et al. [55] used PCR techniques to amplify DNA from
exfoliated cytology samples from oral carcinomas, for
analysis of Restriction-Fragment Length Polymorphisms
(RFLPs). They found that 66% of the tumours studied
showed LOH at one position in the p53 sequence, while
55% showed LOH at some other location. PCR and RFLP
analysis have also been used for the detection of microsat-
ellite markers, i.e. short repetitive DNA sequences. Micro-
satellite mutations, LOH or instability (MI) are all
characteristic of the squamous cell carcinomas of head
and neck, and can thus be used as molecular markers of
malignancy. Microsatellite regions are distributed along
the genome and have been widely and satisfactorily used
as molecular markers for carcinogenesis. Alterations in
these regions have been used as clonal markers and for
detecting tumoral cells among normal cells [56,57]. Sev-
eral studies have demonstrated these by using microsatel-
lite markers that alterations in certain regions of
chromosomes 3p, 9p, 17p and 18q are associated with the
development of head and neck squamous cell carcinomas
[58,59]. Nunes et al.[60] performed a microsatellite anal-
ysis of cells sampled from the oral cavity of oral and
oropharyngeal cancer patients by exfoliative cytology and
by mouthwash, finding LOH in 84% of samples, though
with differences depending on tumour stage. These
authors suggested that techniques of this type might be
useful for early diagnosis and for patient monitoring. In
another study, Spafford et al. identified genetic alterations
(LOH or MI) in all of the malignant lesions of the oral cav-
ity included in their sample. [6] Conversely, none of their
healthy patients showed such alterations, indicating the
very high specificity of these methods.
3. Viral genome studies
Archival cytology slides can also be used for HPV DNA
detection with ISH. The diagnosis of metastatic lesions
usually is determined by fine-needle aspiration. Human
papillomavirus (HPV) is now being considered as a caus-
ative agent in a subset of HNSCC (FF). Presence of HPV
DNA by in situ hybridization (ISH) in metastatic lesions
from HNSCC using alcohol-fixed, archival, cytopatholog-
ical material; was studied and the cytologic features of
HPV-positive metastatic lesions of HNSCC were charac-
terized; and HPV DNA and the origin of metastatic lesions
was correlated [61]
4.Proliferation index and AgNOR analysis
Ki 67 has been studied in oral cytological smears using
Immunocytochemistry to evaluate the nature of lesion
and response to treatment. Sharma et al, evaluated Ki-67
expression in cytologic scrapes from oral squamous cell
carcinoma before and after 24 Gray radiotherapy in 43
patients. Ki-67 expression was seen in an extremely small
number of cells. Only 10 tumours showed positive cells,
and the labeling index in them varied from 0.1 % to 0.01
%. After 24 Gray irradiation, no case showed Ki-67 posi-
tive cells[62]. The validity of oral cytology for analyzing
the number of keratinised cells and the nucleolar activity
(AgNORs) in smoking patients has recently been demon-
strated [63]. Remmerbach reported on AgNOR analysis in
oral cytology and concluded that this may be used as a
routine method for diagnosing oral cancer [64].
5. Immunohistochemical identification of tumour markers
The identification of tumoral markers, notably cytokerat-
ins in smears from the oral cavity has attracted considera-
ble interest. Cytokeratin expression profile provides
useful information on cell differentiation status [64] but
its potential for early diagnosis of oral cancer is limited
[66]. However, certain cytokeratins, such as K8 and K19
are useful if not definitive indicators of malignancy, par-
ticularly if their presence is interpreted in conjunction
with other information, such as DNA profile [67,68].
Conclusion
Oral cytology is becoming increasingly important in the
early diagnosis of oral cancers, as a procedure for obtain-
ing cell samples that can then be analysed by sophisti-
cated diagnostic techniques such as cytomorphometry,
DNA cytometry, and molecular analyses. The advent of
techniques like Toluidine blue staining, brush biopsy and
application of sophisticated computer programs has
changed the scenario and made the interpretation of find-
ings far more reliable. than earlier. The cytological study
of oral cavity cells is simple and rapid, non-aggressive and
relatively painless: it is thus well accepted by patients and
suitable for routine application in population screening
programmes, for early analysis of suspect lesions, and for
pre-and post-treatment monitoring of confirmed malig-
nant lesions.
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